Annual Cash & Cash Equivalents
$1.02 B
+$75.00 M+7.94%
31 December 2023
Summary:
Xylem annual cash & cash equivalents is currently $1.02 billion, with the most recent change of +$75.00 million (+7.94%) on 31 December 2023. During the last 3 years, it has fallen by -$856.00 million (-45.65%). XYL annual cash & cash equivalents is now -45.65% below its all-time high of $1.88 billion, reached on 31 December 2020.XYL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$989.00 M
+$174.00 M+21.35%
30 September 2024
Summary:
Xylem quarterly cash and cash equivalents is currently $989.00 million, with the most recent change of +$174.00 million (+21.35%) on 30 September 2024. Over the past year, it has increased by +$284.00 million (+40.28%). XYL quarterly cash and cash equivalents is now -47.25% below its all-time high of $1.88 billion, reached on 31 December 2020.XYL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XYL Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.9% | +40.3% |
| 3 y3 years | -45.6% | -21.2% |
| 5 y5 years | +244.3% | +118.3% |
XYL Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -45.6% | +7.9% | -26.7% | +40.3% |
| 5 y | 5 years | -45.6% | +244.3% | -47.3% | +118.3% |
| alltime | all time | -45.6% | +1158.0% | -47.3% | +655.0% |
Xylem Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $989.00 M(+21.3%) |
| June 2024 | - | $815.00 M(-13.9%) |
| Mar 2024 | - | $947.00 M(-7.1%) |
| Dec 2023 | $1.02 B(+7.9%) | $1.02 B(+44.5%) |
| Sept 2023 | - | $705.00 M(-0.4%) |
| June 2023 | - | $708.00 M(-15.4%) |
| Mar 2023 | - | $837.00 M(-11.3%) |
| Dec 2022 | $944.00 M(-30.0%) | $944.00 M(-20.4%) |
| Sept 2022 | - | $1.19 B(+6.6%) |
| June 2022 | - | $1.11 B(-0.4%) |
| Mar 2022 | - | $1.12 B(-17.2%) |
| Dec 2021 | $1.35 B(-28.1%) | $1.35 B(+7.5%) |
| Sept 2021 | - | $1.25 B(-31.8%) |
| June 2021 | - | $1.84 B(+9.0%) |
| Mar 2021 | - | $1.69 B(-10.0%) |
| Dec 2020 | $1.88 B(+159.0%) | $1.88 B(+33.7%) |
| Sept 2020 | - | $1.40 B(-11.1%) |
| June 2020 | - | $1.58 B(+113.4%) |
| Mar 2020 | - | $739.00 M(+2.1%) |
| Dec 2019 | $724.00 M(+144.6%) | $724.00 M(+59.8%) |
| Sept 2019 | - | $453.00 M(+18.3%) |
| June 2019 | - | $383.00 M(+39.3%) |
| Mar 2019 | - | $275.00 M(-7.1%) |
| Dec 2018 | $296.00 M(-28.5%) | $296.00 M(-26.7%) |
| Sept 2018 | - | $404.00 M(+25.9%) |
| June 2018 | - | $321.00 M(+8.1%) |
| Mar 2018 | - | $297.00 M(-28.3%) |
| Dec 2017 | $414.00 M | $414.00 M(+46.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | $283.00 M(-1.7%) |
| June 2017 | - | $288.00 M(+0.3%) |
| Mar 2017 | - | $287.00 M(-6.8%) |
| Dec 2016 | $308.00 M(-54.7%) | $308.00 M(-53.3%) |
| Sept 2016 | - | $659.00 M(+12.5%) |
| June 2016 | - | $586.00 M(-50.9%) |
| Mar 2016 | - | $1.19 B(+75.4%) |
| Dec 2015 | $680.00 M(+2.6%) | $680.00 M(+11.3%) |
| Sept 2015 | - | $611.00 M(+1.8%) |
| June 2015 | - | $600.00 M(+8.3%) |
| Mar 2015 | - | $554.00 M(-16.4%) |
| Dec 2014 | $663.00 M(+24.4%) | $663.00 M(+25.3%) |
| Sept 2014 | - | $529.00 M(+17.6%) |
| June 2014 | - | $450.00 M(-3.4%) |
| Mar 2014 | - | $466.00 M(-12.6%) |
| Dec 2013 | $533.00 M(+5.8%) | $533.00 M(+35.3%) |
| Sept 2013 | - | $394.00 M(+9.4%) |
| June 2013 | - | $360.00 M(-4.0%) |
| Mar 2013 | - | $375.00 M(-25.6%) |
| Dec 2012 | $504.00 M(+58.5%) | $504.00 M(+18.9%) |
| Sept 2012 | - | $424.00 M(+18.4%) |
| June 2012 | - | $358.00 M(+3.2%) |
| Mar 2012 | - | $347.00 M(+9.1%) |
| Dec 2011 | $318.00 M(+142.7%) | $318.00 M(+72.8%) |
| Sept 2011 | - | $184.00 M(+19.5%) |
| Mar 2011 | - | $154.00 M(+17.6%) |
| Dec 2010 | $131.00 M(+61.7%) | $131.00 M |
| Dec 2009 | $81.00 M | - |
FAQ
- What is Xylem annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Xylem?
- What is Xylem annual cash & cash equivalents year-on-year change?
- What is Xylem quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Xylem?
- What is Xylem quarterly cash and cash equivalents year-on-year change?
What is Xylem annual cash & cash equivalents?
The current annual cash & cash equivalents of XYL is $1.02 B
What is the all time high annual cash & cash equivalents for Xylem?
Xylem all-time high annual cash & cash equivalents is $1.88 B
What is Xylem annual cash & cash equivalents year-on-year change?
Over the past year, XYL annual cash & cash equivalents has changed by +$75.00 M (+7.94%)
What is Xylem quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of XYL is $989.00 M
What is the all time high quarterly cash and cash equivalents for Xylem?
Xylem all-time high quarterly cash and cash equivalents is $1.88 B
What is Xylem quarterly cash and cash equivalents year-on-year change?
Over the past year, XYL quarterly cash and cash equivalents has changed by +$284.00 M (+40.28%)